ES8600057A1 - Un procedimiento para obtener anticuerpos monoclonales humanos contra toxina bacteriana - Google Patents

Un procedimiento para obtener anticuerpos monoclonales humanos contra toxina bacteriana

Info

Publication number
ES8600057A1
ES8600057A1 ES526097A ES526097A ES8600057A1 ES 8600057 A1 ES8600057 A1 ES 8600057A1 ES 526097 A ES526097 A ES 526097A ES 526097 A ES526097 A ES 526097A ES 8600057 A1 ES8600057 A1 ES 8600057A1
Authority
ES
Spain
Prior art keywords
monoclonal antibodies
antibodies against
bacterial toxins
human monoclonal
against bacterial
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES526097A
Other languages
English (en)
Other versions
ES526097A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Rochester
Original Assignee
University of Rochester
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Rochester filed Critical University of Rochester
Publication of ES526097A0 publication Critical patent/ES526097A0/es
Publication of ES8600057A1 publication Critical patent/ES8600057A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
    • C07K16/1282—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Clostridium (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
    • C07K16/1285—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Corynebacterium (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

PROCEDIMIENTO PARA OBTENER ANTICUERPOS MONOCLONALES HUMANOS CONTRA UNA TOXINA BACTERIANA.COMPRENDE: A) PREPARAR CELULAS HUMANAS CAPACES DE PRODUCIR ANTICUERPOS CONTRA UNA TOXINA BACTERIANA; B) FUSIONAR A UNOS 37JC, EN PRESENCIA DE UN AGENTE DE FUSIONAMIENTO, LAS CELULAS HUMANAS, CON CELULAS DE MIELOMA EN UNA PROPORCION QUE VARIA DE 20:1 HASTA 1:3 ENTRE LAS CELULAS HUMANAS Y LAS CELULAS DE MIELOMA, CON LO QUE SE OBTIENE HIBRIDOS CELULARES FUSIONADOS; C) PROPAGAR LOS HIDRIDOS CELULARES FUSIONADOS A 37JC IN VITRO, EN UN MEDIO NUTRIENTE, O EN UN MEDIO ANIMAL APROPIADO; Y D) RECOGER LOS ANTICUERPOS PRODUCIDOS POR LOS HIBRIDOS CELULARES FUSIONADOS.SE UTILIZAN PARA PREVENERNI LA APARICION DE LA ENFERMEDAD INDUCIDA POR LA TOXINA, TAL COMO EL TETANO Y LA DIFTERIA.
ES526097A 1982-09-30 1983-09-29 Un procedimiento para obtener anticuerpos monoclonales humanos contra toxina bacteriana Expired ES8600057A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US42874782A 1982-09-30 1982-09-30

Publications (2)

Publication Number Publication Date
ES526097A0 ES526097A0 (es) 1985-10-01
ES8600057A1 true ES8600057A1 (es) 1985-10-01

Family

ID=23700239

Family Applications (3)

Application Number Title Priority Date Filing Date
ES526097A Expired ES8600057A1 (es) 1982-09-30 1983-09-29 Un procedimiento para obtener anticuerpos monoclonales humanos contra toxina bacteriana
ES530853A Expired ES8604421A1 (es) 1982-09-30 1984-03-22 Un metodo para separar una toxina bacteriana de una muestra biologica
ES530852A Expired ES8501443A1 (es) 1982-09-30 1984-03-22 Un metodo de ensayo de diagnostico para detectar una toxina bacteriana

Family Applications After (2)

Application Number Title Priority Date Filing Date
ES530853A Expired ES8604421A1 (es) 1982-09-30 1984-03-22 Un metodo para separar una toxina bacteriana de una muestra biologica
ES530852A Expired ES8501443A1 (es) 1982-09-30 1984-03-22 Un metodo de ensayo de diagnostico para detectar una toxina bacteriana

Country Status (8)

Country Link
EP (2) EP0440266A3 (es)
AT (1) ATE70309T1 (es)
AU (1) AU567693B2 (es)
CA (1) CA1262238A (es)
DE (1) DE3382474D1 (es)
DK (1) DK450183A (es)
ES (3) ES8600057A1 (es)
IE (1) IE60439B1 (es)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2907484A (en) * 1983-06-27 1985-01-03 N L Industries Inc. Drill stem logging system
US4834975A (en) * 1984-05-25 1989-05-30 Genetics Corporation Human monoclonal antibodies to serotypic lipopolysaccharide determinants on gram-negative bacteria and their production
FI853395L (fi) * 1984-09-05 1986-03-06 Cetus Corp Monoklonala antikroppar som blockerar gram-negativ bakterieendotoxin.
JP2691708B2 (ja) * 1984-09-26 1997-12-17 住友製薬株式会社 ヒトモノクローナル抗体およびその製法
GB8426463D0 (en) * 1984-10-19 1984-11-28 Technology Licence Co Ltd Monoclonal antibodies
GB8426464D0 (en) * 1984-10-19 1984-11-28 Technology Licence Co Ltd Monoclonal antibodies
GB8426470D0 (en) * 1984-10-19 1984-11-28 Technology Licence Co Ltd Monoclonal antibodies
AU597877B2 (en) * 1984-12-26 1990-06-14 Teijin Limited Anti-pseudomonas aeruginosa human monoclonal antibody
US4818687A (en) * 1985-02-28 1989-04-04 Massachusetts Institute Of Technology Affinity column and process for detection of low molecular weight toxic substances
US4677070A (en) * 1985-04-26 1987-06-30 Cetus Corporation Pseudomonas aeruginosa exotoxin A antibodies, their preparation and use
AU5991786A (en) * 1985-06-06 1987-01-07 Genetic Systems Corporation Protective human monoclonal antibodies to pseudomonas aeruginosa exotoxin a
IL81370A (en) * 1986-02-07 1991-06-30 Genetic Systems Corp Pharmaceutical and diagnostic compositions comprising a plurality of human monoclonal antibodies for the treatment of bacterial diseases,methods for the preparation of the compositions and antibodies and kits containing said compositions
USRE35862E (en) * 1986-08-18 1998-07-28 Emisphere Technologies, Inc. Delivery systems for pharmacological agents encapsulated with proteinoids
US5578323A (en) 1992-06-15 1996-11-26 Emisphere Technologies, Inc. Proteinoid carriers and methods for preparation and use thereof
US6221367B1 (en) 1992-06-15 2001-04-24 Emisphere Technologies, Inc. Active agent transport systems
US5451410A (en) * 1993-04-22 1995-09-19 Emisphere Technologies, Inc. Modified amino acids for encapsulating active agents
US6331318B1 (en) 1994-09-30 2001-12-18 Emisphere Technologies Inc. Carbon-substituted diketopiperazine delivery systems
US5541155A (en) 1994-04-22 1996-07-30 Emisphere Technologies, Inc. Acids and acid salts and their use in delivery systems
US5443841A (en) 1992-06-15 1995-08-22 Emisphere Technologies, Inc. Proteinoid microspheres and methods for preparation and use thereof
US5693338A (en) 1994-09-29 1997-12-02 Emisphere Technologies, Inc. Diketopiperazine-based delivery systems
US5447728A (en) * 1992-06-15 1995-09-05 Emisphere Technologies, Inc. Desferrioxamine oral delivery system
US5629020A (en) * 1994-04-22 1997-05-13 Emisphere Technologies, Inc. Modified amino acids for drug delivery
US5714167A (en) 1992-06-15 1998-02-03 Emisphere Technologies, Inc. Active agent transport systems
US6099856A (en) 1992-06-15 2000-08-08 Emisphere Technologies, Inc. Active agent transport systems
US5792451A (en) 1994-03-02 1998-08-11 Emisphere Technologies, Inc. Oral drug delivery compositions and methods
US5811127A (en) 1992-06-15 1998-09-22 Emisphere Technologies, Inc. Desferrioxamine oral delivery system
US5401516A (en) 1992-12-21 1995-03-28 Emisphere Technologies, Inc. Modified hydrolyzed vegetable protein microspheres and methods for preparation and use thereof
US5958457A (en) 1993-04-22 1999-09-28 Emisphere Technologies, Inc. Compositions for the delivery of antigens
US5709861A (en) 1993-04-22 1998-01-20 Emisphere Technologies, Inc. Compositions for the delivery of antigens
US5643957A (en) 1993-04-22 1997-07-01 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US6090958A (en) 1995-03-31 2000-07-18 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US5866536A (en) 1995-03-31 1999-02-02 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US5965121A (en) 1995-03-31 1999-10-12 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
BR9604880A (pt) 1995-03-31 1998-05-19 Emisphere Tech Inc Composto composição forma de unidade de dosagem métodos para administração de um agente biologicamente ativo para preparar uma composição para administração de um agente ativo e para preparar um composto e composição farmacológica
US5650386A (en) 1995-03-31 1997-07-22 Emisphere Technologies, Inc. Compositions for oral delivery of active agents
US6001347A (en) 1995-03-31 1999-12-14 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US5989539A (en) 1995-03-31 1999-11-23 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US5820881A (en) 1995-04-28 1998-10-13 Emisphere Technologies, Inc. Microspheres of diamide-dicarboxylic acids
US5824345A (en) 1995-06-07 1998-10-20 Emisphere Technologies, Inc. Fragrances and flavorants
US6051258A (en) 1995-06-07 2000-04-18 Emisphere Technologies, Inc. Proteinoid emulsions and methods for preparation and use thereof
US5750147A (en) 1995-06-07 1998-05-12 Emisphere Technologies, Inc. Method of solubilizing and encapsulating itraconazole
US5667806A (en) 1995-06-07 1997-09-16 Emisphere Technologies, Inc. Spray drying method and apparatus
DE19681560T1 (de) 1995-09-11 1998-08-20 Emisphere Tech Inc Verfahren zur Herstellung von omega-Aminoalkansäure-Derivaten aus Cycloalkanonen
CA2258264A1 (en) 1996-06-14 1997-12-18 Emisphere Technologies, Inc. Microencapsulated fragrances and method for preparation
US6313088B1 (en) 1997-02-07 2001-11-06 Emisphere Technologies, Inc. 8-[(2-hydroxy-4-methoxy benzoyl) amino]-octanoic acid compositions for delivering active agents
US5990166A (en) 1997-02-07 1999-11-23 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US6358504B1 (en) 1997-02-07 2002-03-19 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US5939381A (en) 1997-02-07 1999-08-17 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US5879681A (en) 1997-02-07 1999-03-09 Emisphere Technolgies Inc. Compounds and compositions for delivering active agents
US6060513A (en) 1997-02-07 2000-05-09 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US5804688A (en) 1997-02-07 1998-09-08 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US5876710A (en) 1997-02-07 1999-03-02 Emisphere Technologies Inc. Compounds and compositions for delivering active agents
US5863944A (en) 1997-04-30 1999-01-26 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US5962710A (en) 1997-05-09 1999-10-05 Emisphere Technologies, Inc. Method of preparing salicyloylamino acids
WO2018078643A1 (en) * 2016-10-26 2018-05-03 Bharat Serums And Vaccines Ltd. Monoclonal antibodies neutralizing the tetanus toxin
CN108218984B (zh) * 2017-12-29 2018-10-26 珠海泰诺麦博生物技术有限公司 一种抗破伤风毒素的全人源中和抗体

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA783261B (en) * 1977-06-15 1979-06-27 Wistar Inst Method of producing antibodies
US4196265A (en) 1977-06-15 1980-04-01 The Wistar Institute Method of producing antibodies
US4172124A (en) 1978-04-28 1979-10-23 The Wistar Institute Method of producing tumor antibodies
US4193983A (en) * 1978-05-16 1980-03-18 Syva Company Labeled liposome particle compositions and immunoassays therewith
US4271145A (en) 1979-10-22 1981-06-02 The Massachusetts General Hospital Process for producing antibodies to hepatitis virus and cell lines therefor
WO1982001461A1 (en) * 1980-07-18 1982-05-13 Leland Stanford Junior Univ Human hybridomas,precursors and products
NZ198851A (en) 1980-11-07 1984-07-31 Wistar Inst Stable,continuous human myeloma cell line capable of hybridisation with antibody-producing cells:production of hybrid cell line
US4529694A (en) * 1982-04-16 1985-07-16 The Children's Medical Center Corporation Cell fusion
CA1240937A (en) * 1982-07-26 1988-08-23 Gordon R. Dreesman Monoclonal igm antibodies and method of preparation
AU585200B2 (en) * 1983-05-06 1989-06-15 Velos Group Monoclonal antibodies reactive with endotoxin core

Also Published As

Publication number Publication date
ATE70309T1 (de) 1991-12-15
ES526097A0 (es) 1985-10-01
ES530853A0 (es) 1986-02-01
AU1969683A (en) 1984-04-05
EP0105804A2 (en) 1984-04-18
EP0440266A3 (en) 1991-08-28
ES8604421A1 (es) 1986-02-01
DK450183D0 (da) 1983-09-29
IE60439B1 (en) 1994-07-13
ES530852A0 (es) 1984-11-16
CA1262238C (en) 1989-10-10
EP0440266A2 (en) 1991-08-07
IE832295L (en) 1984-03-30
DE3382474D1 (de) 1992-01-23
DK450183A (da) 1984-03-31
CA1262238A (en) 1989-10-10
ES8501443A1 (es) 1984-11-16
AU567693B2 (en) 1987-12-03
EP0105804B1 (en) 1991-12-11
EP0105804A3 (en) 1986-08-13

Similar Documents

Publication Publication Date Title
AU567693B2 (en) Human monoclonal antibodies against bacterial toxins
PH16642A (en) Complement-fixing monoclonal antibody to human t cells,and methods of preparing same
AU577745B2 (en) Somatic human hybridoma fusion partner for the production of human monoclonal antibodies
GR72923B (es)
FI101937B1 (fi) Menetelmä monoklonaalisen vasta-aineen tuottamiseksi, joka reagoi ihmisen cachectiinin kanssa
ES8705975A1 (es) Un metodo de deteccion o localizacion de celulas de carcinoma humano.
JPS6447378A (en) Monoclonal antibody to black tumor related antigen, hybrid cell line for producing the same and use thereof
AU545185B2 (en) Hybrid cell line
PH16567A (en) Hybrid cell line for producing monoclonal antibody to human cytotoxic and suppressor t cells,antibody and methods
JPS6463376A (en) Hybridmer
EP0178891A3 (en) Human-human hybrid cell lines that produce antibodies against antigenic determinants on cancer cells
ES8503371A1 (es) Procedimiento para preparar nuevos anticuerpos de igg de raton con especificidad anti-interferon de humano
AU2456888A (en) Monoclonal antibodies specific for HIV and hybridomas for their production
KR850006705A (ko) 항파상풍항체 생산 인체-인체 하이브리도마의 제조방법
EP0225583A3 (en) Monoclonal anti-human granulocyte colony stimulating factor antibody
EP0166458A3 (en) Monoclonal antibody capable of specifically distinguishing human hepato-carcinoma cells
ES8609465A1 (es) Procedimiento para preparar nuevos anticuerpos monoclonales de raton con especificidad anti-interferon de humano
ZA805743B (en) Hybrid cell line for producing monoclonal antibody to human cytotoxic and supressor t cells, antibody, and methods
HRP940830B1 (en) Hybrid cell line for producing monoclonal antibody to a human t cell antigen, antibody, and methods
HRP940809B1 (en) Hybrid cell line for producing complement-fixing monoclonal antibody to human t cells, antibody and methods
IL67944A0 (en) Antibodies and antigens useful in the diagnosis and treatment of cancer,methods for the production thereof and methods for testing for the presence of cancer cells using the same

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20050604